Severe ticlopidine-induced cholestatic syndrome

Blood Purification

Volumn 25, Issue 5-6, 2008, Pages 441-445

  Mambelli, Emanuele ^a   Mancini, Elena ^a   Casanova, Silvia ^a   Di Felice, Antonio ^a   Santoro, Antonio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Iatrogenic cholestasis; Intrahepatic cholestasis; Liver kidney transplantation; Ticlopidine induced cholestasis; Toxico pathogenous liver insufficiency

Indexed keywords

BILIRUBIN; TICLOPIDINE;

ADULT; ARTERIOVENOUS FISTULA; ARTERY THROMBOSIS; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLESTASIS; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DIALYSIS; DISEASE COURSE; DRUG WITHDRAWAL; GENERAL CONDITION DETERIORATION; GENERAL CONDITION IMPROVEMENT; HUMAN; HUMAN TISSUE; KIDNEY GRAFT; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER GRAFT; MALE; PATIENT MONITORING; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT WITHDRAWAL; VASCULAR ACCESS;

CHOLESTASIS, INTRAHEPATIC; HEPATITIS, TOXIC; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS; TICLOPIDINE;

EID: 38849187383     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111033     Document Type: Article

References (25)

1. Gent M, Blakely JA, Easton JD, et al: The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989;ii:1215-1220.
2. Mc Tavish D, Faulds D, Goa KL: Ticlopidine: an updated review of its pharmacology and therapeutic use in platelet-dependent disorders. Drugs 1990;40:238-259.
3. Various authors: Piastrine 1995. Il rischio vascolare: problemi e soluzioni. Atti del Convegno Internazionale, Milano, 17/11/95. Salerno, Momento Medico, 1996.
4. Guzzini F, Banfi L, Gomitoli A, Marchegiani A, Novati P, Mesina M, Frigerio B: Due casi di colestasi acuta da Ticlopidina. Recenti Prog Med 1997;88:124-125.
5. Leung PS, Coppel RL, Ansari A, Munoz S, Gershwin ME: Antimitochondrial antibodies in primary biliary cirrhosis. Semin Liver Dis 1997;17:61-69.
6. Heathcote J: Treatment of primary biliary cirrhosis. J Gastroenterol Hepatol 1996;11:605-609.
7. Czaja A, Carpenter HA: Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci 1996;41:305-314.
8. Ponsioen CI, Tytgat GN: Primary sclerosing colangitis: a clinical review. Am J Gastroenterol 1998;93:515-523.
9. Bansi DS, Fleming KA, Chapman RW: Importance of antineutrophil cytoplasmic antibodies in primary sclerosing colangitis and ulcerative colitis: prevalence, titres and IgG subclass. Gut 1996;38:384-389.
10. Sartin JS, Walker RC: Granulomatous hepatitis: a retrospective review of 88 cases at the Mayo clinic. Mayo Clin Proc 1991;66:914-918.
11. Ludwig J: Idiopathic adulthood ductopenia: an update. Mayo Clin Proc 1998;73:285-291.
12. Abe H, Kubota K, Makuuchi M: Obstructive jaundice secondary to Hodgkin's disease. Am J Gastroenterol 1997;92:526-527.
13. Navasa M, Rimola A, Rodes J: Bacterial infections in liver disease. Semin Liver Dis 1997;17:323-333.
14. Hagmeyer KO, Stein J: Hepatotoxicity associated with carvedilol. Ann Pharmacother 2001;35:1364-1366.
15. Takekuma Y, Takenaka T, Kiyokawa M, Yamazaki K, Okamoto H, Kitabatake A, et al: Contribution of polymorphisms in UDP-glucuronosyltransferase and CYP2D6 to the individual variation in disposition of carvedilol. J Pharm Pharmacol Sci 2006;9:101-112.
16. Grieco A, Vecchio F, Gasbarrini G, et al: Cholestatic hepatitis due to ticlopidine: clinical and histological recovery after drug withdrawal: case report and review of the literature. Eur J Gastroenterol Hepatol 1998;10:713-715.
17. Kubin CJ, Sherman O, Hussain KB, Feinman L: Delayed onset ticlopidine-induced cholestatic jaundice. Pharmacotherapy 1999;18:1006-1010.
18. Placci A, Melandri G, Cecilioni L, Valgimigli M, Bolondi L, Branzi A: Ittero colestatico a comparsa ritardata dopo trattamento per un mese con Ticlopidina. Ital Heart J Suppl 2001;2:1240-1242.
19. Klepser TB, Jogerst GJ: Ticlopidine-induced elevation of liver enzymes. Pharmacotheraphy 1997;17:819-821.
20. Amaro P, Nunes A, Macoas S, Ministro P, et al: Ticlopidine-induced prolonged cholestasis: a case report. Eur J Gastroenterol Hepatol 1999;11:673-676.
21. Alberti L, Alberti-Flor JJ: Ticlopidine-induced cholestatic hepatitis successfully treated with corticosteroids (letter). Am J Gastroenterol 2002;97:1072.
22. Tsai MH, Tsai SL Chen TC, Liaw YF: Ticlopidine-induced cholestatic hepatitis with antinuclear antibody in serum. J Formosa Med Assoc 2000;99:866-869.
23. Iqbal M, Goenke P, Young MF, Eapen T, Borthwick TR: Ticlopidine-induced cholestatic hepatitis: report of three cases and review of the literature. Dig Dis Sci 1998;43:2223-2226.
24. Adler M, Ros P, Cremer M, Quiriny M, Henry JP, Lecoq E: Lésions hépatiques induites par les médicaments. Rev Med Brux 1986;7:81.
25. Lopez Lopez M, Martin Lopez A, Moreno Feliu R: Ticlopidine, cholestasis and hepatic nodules. Med Clin (Barc) 2001;117:477.